Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Helping Youth Avoid Risky Behavior: Family-Based Program
Children"s behavior is determined, in part, by their genes and by the settings in which they develop. A new longitudinal study describes how a family-based prevention program helped rural African American teens avoid engaging in risky behaviors, even if some of them may have had a genetic risk to do so.
generic viagra online
Medicare Reimbursement Issues Enter Health Reform Debate
New legislation introduced yesterday would attempt to shift Medicare reimbursement policy to reward patient health outcomes, rather than the volume of services provided, MinnPost, a nonprofit online news organization, reports. "We need to be sure to keep score," said Sen. Amy Klobuchar, D-Minn., who introduced the bill, according to MinnPost. "That means measuring outcomes and rewarding providers that deliver quality results."
News of the day
Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing By Launching Two Global Trials
Eli Lilly and Company (NYSE: LLY) announced it will begin enrolling patients this month in two separate but identical Phase III clinical trials of solanezumab(i), previously referred to as LY2062430, an anti-amyloid beta monoclonal antibody being investigated as a potential treatment to delay the progression of mild to moderate Alzheimer"s disease. The trials, called EXPEDITION and EXPEDITION 2, will each include a treatment period that lasts 18 months and are expected to enroll a total of 2,000 patients age 55 and over from 16 countries.
Diagnostics

Sol-Gel Anti-Acne Clinical Study Shows Significantly Improved Efficacy And Safety

Sol-Gel Technologies Ltd, a specialty pharmaceuticals company, announced today results from a comparative clinical study. The results demonstrate that the company"s two strength Anti-Acne kits achieved pronounced efficacy and markedly improved tolerability. The study will be presented at the 10th International Congress of Dermatology in Prague, May 20-23, 2009. "As early as week two we noted a very early reduction of acne lesions, which was significantly superior to leading commercial products, and at week four a 75 percent improvement was achieved," said Stanley Shapiro, PhD, Head of Sol-Gel"s Skin Care Science & Technology unit. "Throughout the study Sol-Gel"s high-strength kits were significantly better tolerated than the two commercial products." The Sol-Gel Anti-Acne kits feature Sol-Gel"s patented drug delivery technology. "In the Sol-Gel kits, the proprietary silica microcapsules encase and continuously release the benzoyl peroxide, enabling a significant increase in efficacy and tolerance in comparison to products containing free benzoyl peroxide," said Ofer Toledano, PhD, VP, Research and Development. The principles of the Sol-Gel encapsulation system will also be presented at the Dermatology Congress. Study Methodology Participants in the double-blind, controlled and randomized, 4-week, 4-arm parallel groups were randomized to receive one of Sol-Gel"s kits or of a comparable leading commercial products. Safety and tolerability were assessed by the Principal Investigator dermatologist who also evaluated the rates and grades of erythema, edema, dryness, scaling/peeling, stinging/burning, itching and skin tightness. Efficacy was assessed by lesions count, including total lesions count, inflammatory and non-inflammatory lesions and Investigator Global Assessment by improvement of Severity Score. Sol-Gel"s Anti-Acne Kits Sol-Gel"s Anti-Acne kits provide a fast-acting, highly-effective and well-tolerated benzoyl peroxide-based acne care program. In contrast to other treatments, the kits deliver visible reduction of acne as quickly as within three days and after two weeks significantly out-perform the leading brand in the resolution of acne and remain substantially more effective with continued use. The Kits, available in two strengths, both treat and prevent acne. Starting with the cleanser, toner and lotion, and optionally adding a spot treatment, the Sol-Gel regimens include timed-release benzoyl peroxide in combination with ingredients that clean, heal and balance the skin. They treat the entire face to reveal clear, blemish-free skin faster - without the dryness and skin irritation caused by other acne treatments. Sol-Gel Technologies


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009